🔗 Share this article

A shadow market for unapproved weight-loss medications is being driven by social media fitness personalities and vendors on communication apps, according to recent findings.

Investigational Drug Gaining Traction Online

The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its supposed fat-burning properties. Viewers are encouraged to contact these profiles directly for source information, while also receiving discount codes.

Active Trade on Messaging Platforms

Separately, a flourishing market exists on messaging services, where groups with numerous of participants share “before and after” images, administration instructions and claims of rapid UK delivery. Sellers promote the drug there before redirecting buyers to WhatsApp for transactions.

Learning About The Experimental Drug

Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.

Medical Experts Voice Worries

However, doctors and chemists have cautions that the distribution of what is still an unlicensed drug in the UK is a cause for concern and could lead to users injecting substances of unknown origin.

Some professionals stated the demand for the experimental drug could be linked to the increasing price of approved slimming products such as Mounjaro.

Regulatory Status and Implementation

Selling the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed drug that cannot be promoted or distributed for human use under the British medical regulations.

Several influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still breach pharmaceutical, advertising, and customer laws, potentially leading to penalties, prosecution or prison.

Platform Reaction and Content Removal

According to TikTok, the service has taken down violative material and prohibited associated keywords and search suggestions. The company stated it was committed to keeping the platform safe and allocating resources in enhancing compliance measures.

Online Marketplace Activities

Research also found communities with up to nine thousand participants selling retatrutide using Telegram's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately displays groups with thousands of members, populated with photos of slimming results, glowing testimonials and detailed instructions for mixing or injecting at home.

Within minutes of joining one group, a seller shared WhatsApp details, where most transactions take place. The seller sent an guidebook and promised shipping within 48 hours. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about weight, health issues or previous experience.

Product Information and Costs

Within these communities, messages display black plastic packages with Royal Mail labels, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at residence with sterile water, or pre-filled injectors usually priced at £160 for 20mg. When asked how long a pen should be used, sellers give contradictory responses ranging from a few weeks to “depends on your body”.

Service Moderation and Security Measures

A representative for the messaging service stated it actively moderated dangerous content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are injecting materials they can’t verify. Although the research behind this drug is valid, these online versions may not include what they claim,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the surge in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With prices rising, individuals are turning to online platforms. But fake treatments are extremely risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she explained.

Her staff has already encountered individuals harmed by personal administration from unconfirmed sources. “We recognize the disappointment, but buying from Telegram or communication platforms is gambling with your health,” said Wyllie. “These substances could be impure or improperly measured.”

Manufacturer Statement

A spokesperson from Eli Lilly stated retatrutide was in third stage clinical trials and had not been evaluated or approved by any government authority globally. “Therefore at this time no one can sell [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a company investigational product not yet approved … may expose users to potentially significant medical dangers”.